Financial News
Sunshine Biopharma (NQ: SBFM )
3.050
+0.170
(+5.90%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Sunshine Biopharma
![](https://cdn.benzinga.com/files/images/story/2022/06/08/screenshot_2022-06-08_at_2.50.21_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/26/hospital-g57ccb6e24_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/26/yesterdays_movers.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/25/mid-day_movers_image.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/25/section-2.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/03/screenshot_2022-05-03_at_2.48.53_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/02/binoculars.mostafa-meraji-yvzkre9vfve-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/19916.png?v=0)
![](https://cdn.benzinga.com/files/images/story/2022/04/26/patent_application.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/27/yesterdays_movers.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/26/mid-day_movers_image.jpg)
![](https://investorplace.com/wp-content/uploads/2019/08/healthcare1600d.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/26/yesterdays_movers.png)
![](https://cdn.benzinga.com/files/images/story/2022/04/25/mid-afternoon-market-update_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_7227.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
April 25, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/09/pills-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/25/mid-day-market-update.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/25/mid-day_movers_image.jpg)
![](/next-assets/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2022/04/25/mid-morning-market-update.jpg?width=1200&height=800&fit=crop)
![](https://www.financialnewsmedia.com/wp-content/uploads/2020/12/BIOV.small_.jpg)
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/20/yesterdays_movers.png)
![](https://investorplace.com/wp-content/uploads/2020/07/biopharma-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/19/stop.kai-pilger-1k3vsv7iiic-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_6821.jpeg)
![](https://cdn.benzinga.com/files/images/story/2022/04/19/sbfm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/19/mid-day_movers_image_0.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/19/yesterdays_movers.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.